Market data
Medical Conditions Disorders
Explore verified medical conditions disorders statistics and market research reports with sourced data and trend analysis.
Latest update:
Elif Demirci
Congenital Heart Defects Statistics
CDC reported 2,368 infant deaths from congenital heart disease in the United States in 2021, yet only about 28% of critical cases are diagnosed before discharge, meaning many babies leave the birth facility before they are properly identified. This page ties together how common CHD is worldwide, why pulse oximetry screening can sharpen detection, and what that means for hospitalization, costs, and long term outcomes from infancy into adulthood.
Ibd Statistics
IBD is rising fast worldwide, with incidence climbing 0.46% per year from 1990 to 2017, while the US alone carries an estimated USD 21.9 billion in annual direct and indirect costs. This page connects the clinical bottleneck to daily life and access, from 1.3 million ER visits in 2015 to nearly 1 in 4 patients needing colectomy within a decade and long diagnostic delays that reach beyond 12 months for up to 37%.
Fetal Alcohol Spectrum Disorder Statistics
Fetal Alcohol Spectrum Disorder affects about 1.0 per 1,000 live births globally, yet impacts are far broader once prenatal alcohol exposure is involved, with nearly 90% of people experiencing neurodevelopmental problems and around 2.3 times higher annual health care spending than controls. The page also weighs the cost of delayed diagnosis and limited access against prevention options, from screening that boosts detection by about 30% to brief counseling that can reduce drinking days by roughly 20%, and it maps what support can change for learning, behavior, and long term outcomes.
Breast Cancer Awareness Statistics
Nearly 1 in 8 US women will develop breast cancer, and stage at diagnosis matters so much that localized cases have survival near 99%. This page ties together 2024 funding, recent screening coverage, and the COVID era rebound and delays that left millions of screenings missed to show what mammography does and what still stands in the way.
Angelman Syndrome Statistics
Nearly everyone with Angelman syndrome experiences profound developmental and communication challenges, including severe developmental delay in 100% and minimal or no verbal language in 95 to 100%, yet the most defining symptom is often missed until the pattern emerges, with high voltage delta rhythm on EEG in 95% even when seizures are not obvious. If you want the practical side as well as the emotional weight, this page also brings in the current genetic testing reality with methylation specific PCR first line positive in 95 to 99% and array CGH reaching 99% accuracy, alongside prevalence estimates of about 1 in 12,000 to 1 in 20,000 live births worldwide.
Pregnancy At 41 Statistics
At 41, survival to NICU discharge for singletons is 70%, yet 18.5% are admitted to the Neonatal ICU and congenital anomalies affect 3.5% of offspring, including a 1 in 82 live births Down syndrome risk. It also charts how fertility shifts from a 5% natural conception chance per cycle and about 55% within a year to outcomes like an 11% live birth rate per IVF cycle using your own eggs.
Heart Failure Hospitalization Statistics
Nearly 1 in 4 people are back in the hospital within 30 days after a heart failure discharge, and heart failure admissions drive about 1.3 million hospitalizations in the U.S. each year. This page puts the clinical and financial stakes side by side, from roughly 4% 30 day mortality in practice patterns to healthcare spending projected to reach $69.7 billion by 2030.
Hiv Statistics
With 30.7 million people accessing ART by the end of 2023, the page tracks the shift from millions of new infections toward treatment and prevention coverage. It also highlights the stubborn gaps behind the progress, including that adolescents remain disproportionately affected and that TB still drives deaths among people living with HIV.
Parkinson S Disease Statistics
Parkinson’s disease still affects about 1% of U.S. adults 65+ yet is projected to rise globally, with cases expected to grow 2.3 times from 2016 to 2030. This page pulls together the human impact behind the burden including falls in about 40% of patients, depression in about 30%, and costs reaching billions, alongside treatment outcomes and market forecasts to show what is changing next.
Cancer Recurrence Statistics
Within 5 years of a US cancer diagnosis, 14% of people are expected to face recurrence or progression, and for many cancers the risk is front loaded into the first 2 to 3 years after curative treatment. This page pairs those timing and survival estimates with what patients report and what care costs, including 57% who worry about recurrence and $3.8 billion in annual US survivorship and follow up spending, to show where the real strain shows up and why follow up decisions matter.
Myasthenia Gravis Statistics
From prednisone ranges of about 10 to 20 mg per day and real-world incidence near 1.7 new cases per 100,000 to how 50% of ocular-onset generalized myasthenia gravis patients shift to generalized disease within 2 years, this page pairs everyday dosing and progression with hard diagnostic and crisis risk markers. You will also see why seronegative “double or triple negative” MG can reach around 12.5 to 17.5% of generalized cases and how oxygen-threatening myasthenic crisis hits roughly 10 to 15% of people over the course of disease.
Uti Statistics
UTI care sits at the intersection of clinical timing and public health pressures, from typical uncomplicated cystitis cure in just 2 to 3 days to a landscape where resistant E. coli and antibiotic stewardship can swing total therapy days by 31%. See how UTIs drive outpatient antibiotic use, what real culture tests reveal when symptoms do not mean bacteria, and why faster diagnostics and tighter prescribing guidance can change both outcomes and costs.
Mono Statistics
Mono is often dismissed as a short illness, yet the complication odds are vivid and specific, from splenic rupture in 0.1 to 0.5 percent of cases and Guillain Barré at 1 in 10,000 to myocarditis ECG changes in 1 to 5 percent and troponin elevation in 7 percent. This page also tracks how infections, diagnostics, and outcomes shift by setting and risk profile, including lymphoma risk up to a fourfold rise in the first year and chronic fatigue persisting in 10 to 20 percent at 6 months.
Osteoporosis Statistics
Osteoporosis drives about 8.9 million fractures every year worldwide and affects 158 million people, yet follow up is often uneven, with assessment rising from 35% without fracture liaison services to 65% with them. See how diagnostics, risk tools like FRAX, and treatments such as denosumab or romosozumab stack up against real world adherence and costs, including why persistence beyond 12 months can make a measurable difference.
Adhd Diagnosis Statistics
ADHD shows up in about 1 in 6 U.S. children, yet many get caught in long, uneven diagnostic pathways, with a median wait of 4.5 weeks for child psychiatry and 46.7% receiving no behavioral intervention. The page contrasts that gap with what evidence and outcomes suggest, including that 62% of children with ADHD have comorbid conditions and treatment and delivery patterns can meaningfully change symptom severity, functioning, and risk.
Dysgraphia Statistics
From a DSM-aligned lifetime prevalence of 3.1% for specific learning disorder to writing-related profiles that can affect 13.6% of students in population studies, dysgraphia often hides inside wider classroom patterns. You will see how handwriting accuracy, speed, and written output typically lag behind, how comorbidity with reading, spelling, and ADHD shifts the odds, and which interventions and assistive tools have measurable results.
Autism Global Statistics
Right now about 1.0% of children globally are estimated to have autism spectrum disorder, yet the lived picture runs far beyond identification with roughly 70% of diagnosed children also documented with intellectual disability or developmental delay. From employment gaps and autism care costs to what early intervention and parent mediated programs can change, Autism Global connects prevalence to outcomes, risk factors, and the evidence behind support.
Dcis Survival Statistics
DCIS survival is 98.8% at 10 years for cases diagnosed 2010–2016—see what trials and tumor features reveal about who benefits most.